Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

A fully integrated, animal-free, end-to-end modelling approach to oral drug product development

Risultati finali

Pubblicazioni

Exploring the Cocrystal Landscape of Posaconazole by Combining High-Throughput Screening Experimentation with Computational Chemistry

Autori: Matteo Guidetti, Rolf Hilfiker, Martin Kuentz, Annette Bauer-Brandl, Fritz Blatter
Pubblicato in: Crystal Growth & Design, Numero 23, 2, 2022, Pagina/e 842-852, ISSN 1528-7483
Editore: American Chemical Society
DOI: 10.1021/acs.cgd.2c01072

Polymer-embedded deep eutectic solvents (PEDES) as a novel bio-enabling formulation approach

Autori: Shaida Panbachi , Josef Beranek, Martin Kuentz
Pubblicato in: European Journal of Pharmaceutical Sciences, Numero Volume 186, 1 July 2023, 2023, ISSN 0928-0987
Editore: Elsevier BV
DOI: 10.1016/j.ejps.2023.106463

Projection of Target Drug Particle Size in Oral Formulations Using the Refined Developability Classification System (rDCS)

Autori: Kristian Beran; Eline Hermans; René Holm; Kia Sepassi; Jennifer Dressman
Pubblicato in: Pharmaceutics; Volume 15; Numero 7; Pages: 1909, Numero 1, 2023, ISSN 1999-4923
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics15071909

Microdialysis and nanofiltration allow to distinguish molecularly dissolved from colloid-associated drug concentrations during biomimetic dissolution testing of supersaturating formulations

Autori: Florentin Lukas Holzem, Jeannine Petrig Schaffland, Martin Brandl, Annette Bauer-Brandl, Cordula Stillhart
Pubblicato in: European Journal of Pharmaceutical Sciences, Numero Volume 174, 1 July 2022, 2022, ISSN 0928-0987
Editore: Elsevier BV
DOI: 10.1016/j.ejps.2022.106166

Biopredictive capability assessment of two dissolution/permeation assays, µFLUXTM and PermeaLoopTM, using supersaturating formulations of Posaconazole

Autori: Florentin Lukas Holzem, Anika Weck, Jeannine Petrig Schaffland, Cordula Stillhart, Sandra Klein, Annette Bauer-Brandl, Martin Brandl
Pubblicato in: European Journal of Pharmaceutical Sciences, Numero 176, 2022, Pagina/e 106260, ISSN 0928-0987
Editore: Elsevier BV
DOI: 10.1016/j.ejps.2022.106260

È in corso la ricerca di dati su OpenAIRE...

Si è verificato un errore durante la ricerca dei dati su OpenAIRE

Nessun risultato disponibile